{"meta":{"query_hash":"68fff1edfae6","filters":{"venue":"Clinical Research (Excluding Clinical Trials)"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/68fff1edfae6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Research+%28Excluding+Clinical+Trials%29"},"results":[{"id":"W2953914066","doi":"10.1158/1538-7445.sabcs18-463","title":"Abstract 463: Integrated digital pathology and transcriptome analysis identifies molecular mediators of T cell exclusion in ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Ovarian cancer; Transcriptome; CD8; Cytotoxic T cell; Immunotherapy; Biology; Phenotype; Cancer research; Cancer; Ovarian carcinoma; Immune system; Pathology; Medicine; Immunology; Gene expression; In vitro; Gene; Genetics","score_opus":0.2873265918370317,"score_gpt":0.5490763127051037,"score_spread":0.261749720868072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953914066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982142,0.0011665653,0.012655185,0.00010219147,0.000015084948,0.00007165486,0.0020611838,0.00023665091,0.0015494649],"genre_scores_gemma":[0.9699037,0.00063828315,0.024004983,0.00008235202,0.000021674045,0.00014350837,0.0035656148,0.000043686676,0.0015961736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997876,0.000023526574,0.00001201895,0.000049668393,0.00009924755,0.000027909631],"domain_scores_gemma":[0.99983406,0.000032056665,0.00006125283,0.000015078127,0.00003969047,0.000017787515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031561137,0.00020628142,0.00030801722,0.00079739676,0.00017908005,0.00061661884,0.00012782888,0.00018738495,0.0012224964],"category_scores_gemma":[0.0003475189,0.00010384649,0.00019307506,0.00077353156,0.00021446301,0.00023876493,0.00024049608,0.00027178694,0.0003156279],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005648136,0.00011217015,0.031994767,0.00020070771,0.000037740934,0.00007500522,0.00007101751,0.0010658364,0.9147225,0.00018555527,0.00056472415,0.05040523],"study_design_scores_gemma":[0.00006368739,0.00085222576,0.4920874,0.000040797724,0.00017164202,0.0008456441,0.00024818917,0.02451244,0.4737744,0.00073807326,0.0066378242,0.000027722206],"about_ca_topic_score_codex":0.0005787748,"about_ca_topic_score_gemma":0.0009959441,"teacher_disagreement_score":0.0012224964,"about_ca_system_score_codex":0.00032891147,"about_ca_system_score_gemma":0.00037865614,"threshold_uncertainty_score":0.0040896535},"labels":[],"label_agreement":null},{"id":"W2954662627","doi":"10.1158/1538-7445.sabcs18-3134","title":"Abstract 3134: CCN3 is a prognostic biomarker and functional mediator of prostate cancer bone metastasis","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Prostate cancer; Mediator; Bone metastasis; Medicine; Metastasis; Oncology; Biomarker; Internal medicine; Cancer research; Cancer; Biology","score_opus":0.5839358741185923,"score_gpt":0.5988919893140373,"score_spread":0.014956115195445041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954662627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588905,0.016531616,0.006114669,0.0013328518,0.00022381784,0.00011733676,0.0065919785,0.00037435605,0.009822927],"genre_scores_gemma":[0.98334366,0.0024090528,0.003172769,0.00018321724,0.00007342265,0.00006980967,0.0053020343,0.000026482008,0.0054196035],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998369,0.000013308329,0.000008852619,0.00003250666,0.00008139948,0.000027011803],"domain_scores_gemma":[0.9998859,0.000011477874,0.000032673168,0.0000069003695,0.000033190925,0.000029937299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021716578,0.00045303215,0.00025725624,0.00046082836,0.00032823486,0.00037900227,0.0002771359,0.00038248367,0.0055579944],"category_scores_gemma":[0.00020169876,0.00010496502,0.0002772094,0.00060135225,0.00029477722,0.00022583477,0.00020045716,0.00047614286,0.00083497807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007552557,0.000045116874,0.009950104,0.00031977816,0.000039858583,0.00032491586,0.000029454413,0.00023557835,0.9769115,0.00035960707,0.0020431587,0.008985792],"study_design_scores_gemma":[0.00013119967,0.0004894523,0.251921,0.00007393374,0.00023072025,0.0070123165,0.00012204745,0.0035575193,0.7023284,0.00068762724,0.033406373,0.000039454684],"about_ca_topic_score_codex":0.0024441364,"about_ca_topic_score_gemma":0.002483258,"teacher_disagreement_score":0.0055579944,"about_ca_system_score_codex":0.00079184875,"about_ca_system_score_gemma":0.0005714377,"threshold_uncertainty_score":0.018593311},"labels":[],"label_agreement":null},{"id":"W2954855872","doi":"10.1158/1538-7445.sabcs18-2272","title":"Abstract 2272: Exploratory analysis of T cell repertoire dynamics upon systemic treatment with the oncolytic virus pelareorep in combination with pembrolizumab and chemotherapy in patients with advanced pancreatic adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Pembrolizumab; Oncolytic virus; Gemcitabine; Medicine; Chemotherapy; CD8; Irinotecan; Cancer research; Oncology; Immunotherapy; Internal medicine; Immune system; Immunology; Cancer; Colorectal cancer","score_opus":0.12511971667123817,"score_gpt":0.4509382467694909,"score_spread":0.32581853009825273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954855872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994661,0.000091304406,0.000067363086,0.000012271121,0.000002832972,0.000035991823,0.000057986927,0.0000025475638,0.00026349776],"genre_scores_gemma":[0.9992355,0.00005129363,0.000112811504,0.00003263448,0.000014579463,0.000060897473,0.00023310505,0.0000017897191,0.00025745353],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998721,0.00003562583,0.0000067220053,0.000033002692,0.000019522351,0.00003309179],"domain_scores_gemma":[0.9998429,0.000041282707,0.000021855229,0.00001368589,0.000015602553,0.00006469781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002556123,0.00023669594,0.00045726015,0.00020529698,0.0002662252,0.00029843068,0.00014760859,0.00026392564,0.001225847],"category_scores_gemma":[0.00030512863,0.0001363276,0.0002425446,0.00018544577,0.00016892572,0.00019688124,0.00015581424,0.00047125228,0.0002716025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07947538,0.0111501925,0.36724034,0.0002643975,0.00026155554,0.003542015,0.0007111078,0.001967592,0.4613874,0.000095228315,0.00097530027,0.07292949],"study_design_scores_gemma":[0.003508554,0.1826303,0.75751257,0.000022037426,0.00034965176,0.005309944,0.00042107468,0.003762615,0.042227622,0.00009466531,0.004138051,0.000022911277],"about_ca_topic_score_codex":0.0003425644,"about_ca_topic_score_gemma":0.0003658576,"teacher_disagreement_score":0.001225847,"about_ca_system_score_codex":0.0002446374,"about_ca_system_score_gemma":0.00019583708,"threshold_uncertainty_score":0.004100919},"labels":[],"label_agreement":null},{"id":"W2955358464","doi":"10.1158/1538-7445.sabcs18-4912","title":"Abstract 4912: A snapshot of myeloproliferative neoplasms in the United States: Analysis of the “myMPN” patient registry","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Snapshot (computer storage); Computer science; Medicine; Database","score_opus":0.5550935003392555,"score_gpt":0.5987014889231944,"score_spread":0.043607988583938884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955358464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.652775,0.0017198065,0.0017843039,0.0033190234,0.00011932376,0.0008167526,0.32571968,0.0003974634,0.01334863],"genre_scores_gemma":[0.7132588,0.002522737,0.0059367516,0.0024026097,0.00018766003,0.0021258858,0.27122384,0.00017916791,0.0021626197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952199,0.0014174395,0.0011010432,0.000843989,0.00102595,0.00039162918],"domain_scores_gemma":[0.97869545,0.00347991,0.0089889215,0.0020120044,0.0045445287,0.0022792204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048874393,0.00030613304,0.00057247287,0.0043300213,0.00090504374,0.0016411485,0.0011459318,0.0005516901,0.0039291037],"category_scores_gemma":[0.015239201,0.00041534152,0.0004888237,0.008088785,0.0003040452,0.002024104,0.0030912596,0.0012591411,0.0011316189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017453662,0.00012985623,0.9394361,0.00025568123,0.00013127582,0.00015671762,0.00054944714,0.00021558067,0.00014216681,0.0004740424,0.045316916,0.013017787],"study_design_scores_gemma":[0.00003441638,0.00008595036,0.9771971,0.00031494285,0.00007053752,0.00052835204,0.0013516464,0.0004521595,0.00015576772,0.00015948247,0.019619567,0.000030137653],"about_ca_topic_score_codex":0.024927456,"about_ca_topic_score_gemma":0.029684631,"teacher_disagreement_score":0.024927456,"about_ca_system_score_codex":0.0015284424,"about_ca_system_score_gemma":0.0036430813,"threshold_uncertainty_score":0.04956472},"labels":[],"label_agreement":null},{"id":"W2955594557","doi":"10.1158/1538-7445.sabcs18-4915","title":"Abstract 4915: Optimal frequency of follow up scans on systemictherapy for advanced malignancies","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Nuclear medicine; Regimen; Progression-free survival; Confidence interval; Surgery; Internal medicine; Overall survival","score_opus":0.4580237976289348,"score_gpt":0.5750532241862021,"score_spread":0.11702942655726728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955594557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91774863,0.056565814,0.0072294767,0.0021493868,0.0005074017,0.0015623738,0.0010660236,0.0007083243,0.012462603],"genre_scores_gemma":[0.98452747,0.0059972703,0.005992162,0.00063398614,0.00023330988,0.000614445,0.00051813375,0.000074708696,0.0014085451],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99930656,0.00034792113,0.000068635025,0.000093663126,0.00013088317,0.00005232035],"domain_scores_gemma":[0.9982236,0.0008938311,0.0005173426,0.00012122009,0.00007702065,0.00016696796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018207817,0.00030067938,0.0009594273,0.0003911093,0.00016096659,0.0005625501,0.00033601144,0.00046037213,0.007379858],"category_scores_gemma":[0.0040387684,0.00014690972,0.00075226923,0.00034892958,0.00030263304,0.00057328324,0.00032354012,0.0009465204,0.001198674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08510581,0.0031839088,0.01589115,0.0036616467,0.00089074345,0.000112237234,0.00013194594,0.004669998,0.0070595136,0.00087617134,0.008608056,0.8698088],"study_design_scores_gemma":[0.14931998,0.367405,0.2740658,0.009087139,0.008498159,0.004140851,0.00036287785,0.025244448,0.040891506,0.009216398,0.11151467,0.00025311465],"about_ca_topic_score_codex":0.0002785263,"about_ca_topic_score_gemma":0.0007156187,"teacher_disagreement_score":0.007379858,"about_ca_system_score_codex":0.00050105556,"about_ca_system_score_gemma":0.00055087043,"threshold_uncertainty_score":0.024688065},"labels":[],"label_agreement":null},{"id":"W4251150431","doi":"10.1158/1538-7445.sabcs18-3106","title":"Abstract 3106: Targeting vitamin D signalling in metastatic neuroblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Calcipotriol; Calcitriol receptor; Cancer research; Medicine; Cancer; Metastasis; Internal medicine; In vivo; Neuroblastoma; Vitamin D and neurology; Cell culture; Oncology; Endocrinology; Biology; Immunology; Genetics","score_opus":0.6529813063708557,"score_gpt":0.6331836510641294,"score_spread":0.01979765530672628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251150431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97986114,0.007076289,0.0065256134,0.00030306558,0.0000694375,0.00017841061,0.0017244007,0.00019845317,0.0040632994],"genre_scores_gemma":[0.98057705,0.0043051075,0.009029696,0.00009605164,0.000014650925,0.00009388282,0.001710587,0.000032595573,0.0041403593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992585,0.000007220188,0.0000045230026,0.000015463087,0.00003495821,0.000011978087],"domain_scores_gemma":[0.99995863,0.000007828419,0.000011173629,0.0000029259722,0.000007603877,0.000011777957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094641226,0.0002703799,0.0002893018,0.00038693091,0.00014651215,0.00028802533,0.00027305778,0.0003557805,0.0017241512],"category_scores_gemma":[0.000101819474,0.000103822524,0.00024359791,0.00022315451,0.00017194953,0.000134259,0.00016687796,0.00037753658,0.00039167833],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003426729,0.000057028108,0.00042379877,0.00014820376,0.000013945064,0.00010606676,0.000012966793,0.00040325068,0.9909203,0.00015449763,0.00019657002,0.007220726],"study_design_scores_gemma":[0.0001892677,0.0018758923,0.0062989197,0.000031294177,0.00007622256,0.00127488,0.000034556713,0.0024792464,0.9713037,0.00021431159,0.016208684,0.000013062049],"about_ca_topic_score_codex":0.0008792208,"about_ca_topic_score_gemma":0.001977634,"teacher_disagreement_score":0.0017241512,"about_ca_system_score_codex":0.00041835697,"about_ca_system_score_gemma":0.00029082497,"threshold_uncertainty_score":0.005767882},"labels":[],"label_agreement":null},{"id":"W4253579964","doi":"10.1158/1538-7445.sabcs18-3123","title":"Abstract 3123: Targeting SHP2 and RAS MAPK pathway in neuroblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; MAPK/ERK pathway; Neuroblastoma; PTPN11; Biology; Cell growth; Signal transduction; Protein tyrosine phosphatase; Apoptosis; Effector; Cell culture; Mutation; Immunology; Cell biology; Genetics; Gene; KRAS","score_opus":0.5040751012027124,"score_gpt":0.60227938327089,"score_spread":0.09820428206817766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253579964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97917145,0.007313037,0.0026837266,0.0004269289,0.00018138335,0.00029225546,0.0026650685,0.00021239501,0.007053759],"genre_scores_gemma":[0.9772723,0.006646271,0.0041159354,0.00021993069,0.00003730553,0.00024500364,0.0038360816,0.000028778886,0.007598521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998642,0.0000149967655,0.000014474775,0.000023754015,0.000053047053,0.000029589795],"domain_scores_gemma":[0.9999665,0.0000040866125,0.0000069268644,0.000003434191,0.000005985698,0.000013093507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017231784,0.00054625695,0.00045264754,0.00022865771,0.00020535065,0.0002597948,0.0003150507,0.00032132532,0.002314418],"category_scores_gemma":[0.00006873252,0.00012822944,0.00027903903,0.00023369424,0.00017429536,0.00017058318,0.00023401374,0.00075907214,0.00078727346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005191567,0.00019786014,0.00049112027,0.00020698934,0.000028872215,0.00013790592,0.000015501595,0.0002635833,0.9901839,0.00010465368,0.0005823205,0.0072681997],"study_design_scores_gemma":[0.00019753363,0.00225969,0.006516991,0.000024929057,0.000066231005,0.0008435254,0.000029820896,0.0010917737,0.9781797,0.00005816552,0.010721931,0.000009736632],"about_ca_topic_score_codex":0.0016167646,"about_ca_topic_score_gemma":0.003545602,"teacher_disagreement_score":0.002314418,"about_ca_system_score_codex":0.00043949025,"about_ca_system_score_gemma":0.00051856757,"threshold_uncertainty_score":0.007742524},"labels":[],"label_agreement":null},{"id":"W4254205573","doi":"10.1158/1538-7445.sabcs18-1375","title":"Abstract 1375: Multiplex gene expression using the HyCEAD assay in CTCs isolated with the Parsortix™ system","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Multiplex; Gene; Computational biology; Biology; Computer science; Genetics","score_opus":0.7077130721999437,"score_gpt":0.6386006527521464,"score_spread":0.06911241944779734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254205573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53577024,0.0029290959,0.43882555,0.0005350387,0.00039923933,0.0014922547,0.009229524,0.0028327797,0.007986195],"genre_scores_gemma":[0.4321795,0.0027962036,0.5106941,0.0009417098,0.00020877317,0.0036567093,0.025996903,0.0005532545,0.022972915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971764,0.00048012903,0.00016767494,0.0009042861,0.0010318604,0.00023967598],"domain_scores_gemma":[0.9993374,0.0002638566,0.00007536288,0.000082314946,0.00018235671,0.000058690937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011983418,0.0011504232,0.0008672738,0.0014076568,0.0004999278,0.0010428544,0.0007118793,0.0007645433,0.005982782],"category_scores_gemma":[0.0010186543,0.00057390676,0.0006752991,0.0011662724,0.00071383413,0.00047613608,0.0006594248,0.001429273,0.0020317642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013722629,0.000061251296,0.0008147131,0.000104592575,0.000015346697,0.000017828866,0.000048629536,0.00016345442,0.9926749,0.00018536233,0.00040046242,0.0053761657],"study_design_scores_gemma":[0.00004454206,0.0003590179,0.004843069,0.000020100952,0.000045855937,0.00013155946,0.000032258667,0.005003191,0.9843919,0.00015510985,0.004949719,0.000023577008],"about_ca_topic_score_codex":0.00079505914,"about_ca_topic_score_gemma":0.0018887518,"teacher_disagreement_score":0.005982782,"about_ca_system_score_codex":0.0008141642,"about_ca_system_score_gemma":0.0007377611,"threshold_uncertainty_score":0.020014405},"labels":[],"label_agreement":null}]}